Careers
|
Partnerships
|
Contact
|
Login
LEARN
MORE
LEARN
MORE

Company

Response Biomedical Corp. (Response) has been at the forefront of acute care testing for over 30 years, dedicated to supporting life-saving care through rapid and reliable diagnostics. Headquartered in Canada, we supply high-quality immunoassays to improve patient outcomes because every test result can change a life.
Got Your Back
We build trust through
honesty, accountability,
and mutual support
Take the Lead
We lead by example,
with vision, accountability,
and initiative
Better Every Day
We embrace growth
through continuous learning, feedback, and improvement
Find A Way
We are resourceful,
solution-oriented, and
resilient in the face of challenges

What We Do

The RAMP platform is a global leader in acute care diagnostic testing for triage directly from whole blood samples.  We understand the stresses associated with rapid and accurate diagnosis when every minute counts. We are committed to providing lab-quality results within minutes that medical teams can trust, while reducing the total cost of care.

Who We Are

Response is focused on enabling our strong network of partners to be leaders in their markets by providing high quality diagnostic tests and exceptional levels of support. Response fosters a values-based culture, and we believe the people we work with internally and externally are the cornerstone of our success. Response has a world-class R&D and manufacturing facility in beautiful Vancouver, Canada and our Quality Management System (QMS) is ISO 13485:2016 and MDSAP certified by Intertek. 

Our Purpose

Our core purpose is to improve and save lives globally. We work tirelessly to ensure that patients receive diagnostic results with speed, precision and accuracy so their medical teams can quickly and confidently make informed patient management decisions.

Our Promise to You

We commit to responding to any request within 24 hours, or else we will pay you $500. This commitment reflects our unwavering passion and dedication to providing the best customer experience around the clock. Reach out to us through our 24/7 Response support line at 1-866-525-7267. Our dedicated team is always available to answer any questions or concerns.

Leaders in Our Industry

Response focuses on providing diagnostic tools that aid in the diagnosis of
life-threatening diseases, and we are passionate about raising the bar in acute care diagnostics.

Taso Tsonis, CPA, CA

Interim CEO,
and CFO

Angela Carter

Vice President,
Global Channel Strategy

Contact Our Specialists

24 hour Technical Support available to all RAMP Customers

Faster

Improves turnaround time
for faster triage

Accurate

Provides high quality results
with built in QC

Reliable

Enables clinicians to make
informed decisions
Response Biomedical Corp.
1781 - 75th Avenue W.
Vancouver, BC,
Canada V6P 6P2

DISCOVER

Cardiovascular Infectious Disease Sepsis Women's Health Arbovirus

LEARN

RAMP System RAMP Portal Resources News

CONNECT

Partnership About Careers Contact
Sitemap
|
Privacy Policy
|
Terms and Conditions
©2025 Response Biomedical. All Rights reserved

Book A Demo

"*" indicates required fields

Name*

Meet Us at the Event

"*" indicates required fields

Name*

Technical Support

"*" indicates required fields

Name*

Get A Quote

"*" indicates required fields

Name*

Partnership

"*" indicates required fields

Name*

Angela Carter BSC (Hons)

Vice President, Global Channel Strategy
“We’re working strategically with our partners to help them be leaders in their markets.” Angela Carter has been with Response for 20 years and is responsible for our commercial efforts and support services. Angela plays a key role in working strategically with Response's channel partners to grow our customer base and she is the voice of the customer at Response. Angela is passionate about international business and her in-depth clinical and technical knowledge is a key driver for growth at Response. She has extensive experience in in vitro diagnostics and near patient testing with expertise in sales and marketing, laboratory operations, analytical development, QC and compliance. Prior to Response, Angela's background in biochemistry led to work in molecular biology and proteomics at various labs at SFU, UBC and the University of Toronto. Angela's shift to industry began at ID Biomedical where she worked in assay development for drug-resistant bacteria and her passion for diagnostics grew through her development of an innovative diagnostics design for a novel cancer marker at Kinetek Biotechnology.

TASO Tsonis, CPA, CA

Interim CEO and CFO
Taso Tsonis, joined Response in 2011, bringing a wealth of experience in global finance, accounting, and assurance and stepped into the role of interim CEO in January 2025. As a key member of our leadership team, Taso plays a pivotal role in steering the financial aspects of our operations. In his capacity, Taso oversees critical functions, including budgeting, forecasting, financial controls, and compliance. With a keen eye on maintaining effective financial management, he ensures that our company meets its reporting requirements and manages treasury functions adeptly. A strategic thinker, Taso leads the development and execution of our global long-term financial strategy. His commitment to driving profitable growth has been instrumental in the company’s success. Prior to joining our team, Taso honed his skills in public accounting with Ernst & Young, adding a valuable layer of expertise to our financial leadership. His dedication and proficiency contribute significantly to our overall financial health and success.